PropertyValue
?:abstract
  • Epidemiological data report that several countries with a high prevalence of hypovitaminosis D may have increased susceptibility to complications and mortality due to COVID-19 infection. These reports, however, have limitations given that they derive from observational studies. Nevertheless, while awaiting more robust data, clinicians should treat patients with vitamin D deficiency irrespective of whether or not it has a link with respiratory infections.
?:creator
?:doi
  • 10.1007/s42000-020-00231-9
?:doi
?:journal
  • Hormones_(Athens)
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/326b159b9cab05fe125199ecc4f3b2a651528061.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7360122.xml.json
?:pmcid
?:pmid
?:pmid
  • 32666357.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Vitamin D and COVID-19
?:type
?:year
  • 2020-07-14

Metadata

Anon_0  
expand all